Replies to post #188072 on Anavex Life Sciences Corp (AVXL)

[bas2020]

Appears to be a pay-to-play report...

Also, they are all drugs expected to launch this year. Did you not biocheck that?

[bas2020]

Can you imagine next year's report...

  Name:        Developer:  Indication(s): 2020 Sales forecast: 2024 Sales forecast: 
 "Cellstasis"  Anavex      AD,PDD,Rett,         $1B                  $50B 
  (A2-73)      Life Sc.    MS,ALS,Frag-X, 
                           Autism,Epilepsy

[ClosetInvestor]

That’s because there most likely won’t be any 2-73 sales in 2019. The drug may get to market in late 2019 for an indication, but phase 3 trials and the BLA process take some time.